These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9819457)

  • 1. Combination therapy for hepatitis C infection.
    Liang TJ
    N Engl J Med; 1998 Nov; 339(21):1549-50. PubMed ID: 9819457
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of chronic hepatitis C: interferon alpha-2b alone or in combination with ribavirin].
    Fontaine H; Pol S
    Gastroenterol Clin Biol; 1999 Apr; 23(4):541-4. PubMed ID: 10416124
    [No Abstract]   [Full Text] [Related]  

  • 3. [Efficacy and safety of combination therapy with interferon-alpha and ribavirin in patients with chronic hepatitis C coinfected with human immunodeficiency virus].
    Castéra L; Roulot D
    Gastroenterol Clin Biol; 2000 Oct; 24(10):978-9. PubMed ID: 11185920
    [No Abstract]   [Full Text] [Related]  

  • 4. Ribavirin and chronic hepatitis C infection.
    FDA Consum; 2001; 35(5):3. PubMed ID: 11697089
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic genotype 4 hepatitis C.
    Schafer DF
    Hepatology; 2008 May; 47(5):1791-2; author reply 1793-4. PubMed ID: 18395844
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutagenic effects of ribavirin in vivo.
    Perelson AS; Ribeiro RM
    J Hepatol; 2005 Oct; 43(4):553-5. PubMed ID: 16099528
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in 'true life'.
    Ridruejo E
    Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):195. PubMed ID: 21228684
    [No Abstract]   [Full Text] [Related]  

  • 8. [Difficult-to-treat patient with chronic hepatitis C: a challenge in clinical practice].
    Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):486-7. PubMed ID: 19912678
    [No Abstract]   [Full Text] [Related]  

  • 9. r-Interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders.
    Perasso A; Testino G; Ansaldi F; Venturino V; Icardi GC
    Hepatology; 1999 Jan; 29(1):297-8. PubMed ID: 9935339
    [No Abstract]   [Full Text] [Related]  

  • 10. [Place of consensus type interferon alpha in the management of chronic type C hepatitis].
    Juszczyk J
    Pol Merkur Lekarski; 2003 Apr; 14(82):275-8. PubMed ID: 12868183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C.
    Soza A; Hoofnagle JH
    Hepatology; 2003 Jul; 38(1):267. PubMed ID: 12830010
    [No Abstract]   [Full Text] [Related]  

  • 12. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C.
    Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT
    Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferon-alpha and ribavirin: advances in the therapy of chronic hepatitis C].
    Zeuzem S
    Dtsch Med Wochenschr; 1999 May; 124(20):636-42. PubMed ID: 10370387
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase III Peg-Intron plus Rebetol results released.
    AIDS Read; 2000 Dec; 10(12):702. PubMed ID: 11189740
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peginterferon alpha combined with ribavirin for the treatment of chronic hepatitis C].
    Xu Y; Wang JB
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):415-6. PubMed ID: 22053369
    [No Abstract]   [Full Text] [Related]  

  • 16. Viral hepatitis C.
    Mascitelli L; Pezzetta F
    Lancet; 2004 Feb; 363(9409):661. PubMed ID: 14987902
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcome of combination antiviral therapy in hepatitis C virus infected patients with sickle cell disease.
    Alavian SM; Tabatabaei SV; Ayyub M
    Saudi Med J; 2009 Aug; 30(8):1107-8; author reply 1107-8. PubMed ID: 19668900
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination therapy for chronic hepatitis C.
    Marcellin P
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):135-6. PubMed ID: 10363199
    [No Abstract]   [Full Text] [Related]  

  • 19. Adding ribavirin to interferon alpha-2b for chronic hepatitis C infection increased virological response and nausea.
    Schalm SW
    Gut; 1998 Nov; 43(5):602. PubMed ID: 9824337
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.
    McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK
    N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.